Patents, Trademarks, Trade Secrets, and Copyrights Oh My!


J&J, Amgen end patent infringement suit over colitis drug

"Johnson & Johnson and Amgen Inc. settled a patent-infringement suit over a proposed biosimilar version of the blockbuster ulcerative colitis drug Stelara on the same day that Amgen’s response to a preliminary injunction bid was due."
Bloomberg Law
2023-05-24 06:31:33